Abstract
Since 2018, the FDA has required that U.S. clinical trial results be reported to clinicaltrials.gov within a year of trial completion, but this mandate is often ignored. A recent study found that less than half of U.S. trials submitted results to the site by the deadline. Industry-led trials were the most likely to be reported on time.
©2020 American Association for Cancer Research.
2020
American Association for Cancer Research.
You do not currently have access to this content.